Similar articles

• Once-daily dosing of aminoglycosides: how much monitoring is truly required?

  Winston L, Benowitz N. Winston L, et al. Am J Med. 2003 Feb 15;114(3):239-40. doi: 10.1016/s0002-9343(03)00012-3. Am J Med. 2003. PMID: 12637142 No abstract available.
• Serial pharmacokinetic dosing of aminoglycosides: a community hospital experience.

  Hoffa DE. Hoffa DE. Ther Drug Monit. 1989 Sep;11(5):574-9. Ther Drug Monit. 1989. PMID: 2815234
• Clinical application of aminoglycosides.

  Noone P. Noone P. Br J Audiol. 1982 May;16(2):141-6. doi: 10.3109/03005368209081460. Br J Audiol. 1982. PMID: 6980038 No abstract available.
• [Aminoglycoside nephrotoxicity. III. Changes in subcellular elements].

  Fillastre JP, Morin JP, Bendirdjian JP, Viotte G, Godin M. Fillastre JP, et al. Nephrologie. 1980;1(3):145-52. Nephrologie. 1980. PMID: 7027065 Review. French. No abstract available.
• New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view.

  Lopez-Novoa JM, Quiros Y, Vicente L, Morales AI, Lopez-Hernandez FJ. Lopez-Novoa JM, et al. Kidney Int. 2011 Jan;79(1):33-45. doi: 10.1038/ki.2010.337. Epub 2010 Sep 22. Kidney Int. 2011. PMID: 20861826 Review.